Related Experiment Video

Updated: May 14, 2026

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

Commercial immunoassays in biomarkers studies: researchers beware!

Nader Rifai, Ian D Watson, Greg Miller

    Clinical Chemistry and Laboratory Medicine
    |February 6, 2013
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Developing a Salivary Antibody Multiplex Immunoassay to Measure Human Exposure to Environmental Pathogens09:08

    Developing a Salivary Antibody Multiplex Immunoassay to Measure Human Exposure to Environmental Pathogens

    Published on: September 12, 2016

    Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies07:20

    Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

    Published on: January 28, 2014

    Related Concept Videos

    Enzyme-Linked Immunosorbent Assay01:33

    Enzyme-Linked Immunosorbent Assay

    In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
    There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or quantified.